TABLE 1.
Currently used hematologic tumor-related biomarkers.
| Hematological malignancies | Subtype | DNA | miRNA | Protein | Cell |
|---|---|---|---|---|---|
| Lymphoma | NHL | C-myc, Bcl-, Bcl-6, Bcl-11, P53, P16, B2M, PTPN1, TNFAIP3 | miR-21, miR-155 | C-myc, Bax, Bcl2, CD3/4/7/8/20/22/45 | Ramos |
| HL | B2M, PTPN11, TNFAIP3 | - | CD30/68/80 | R-S | |
| Leukemia | AML | PML/RARα, AML1-ETO, CBFβ-MYH11 | miR-181a, miR-15 | CD33 | HL-60/K562 |
| ALL | FLT3, PRAME, NPM1, C-KIT, CEBPA | miR-128/181/204/218/221/331 | CD10, CD19 | CCRF-CEM | |
| CML | P185BCR/ABL, TEL/AML1, E2A/PBX1, MLL/AF4 | miR-217/221/222 miR-17-92 | ABL | K562 | |
| CLL | PRAME/BCR/ABL, ASS | miR-15/16/29/181 | CD52 | CLL | |
| Multiple myeloma | - | KRAS, NRA, BRAF, TRAF3, CYLD, LTB, TP53, ATM, ATR | miR-21/32/93/133 miR-206/221/222, miR-17-92 | CD30/38, M protein, CRP, LDH | MM |